KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Non-cash Items (2016 - 2022)

Pacific Biosciences Of California (PACB) has 6 years of Non-cash Items data on record, last reported at $58.0 million in Q4 2018.

  • For Q4 2018, Non-cash Items rose 3311.76% year-over-year to $58.0 million; the TTM value through Dec 2018 reached $58.0 million, up 3311.76%, while the annual FY2018 figure was $58.0 million, 3311.76% up from the prior year.
  • Non-cash Items reached $58.0 million in Q4 2018 per PACB's latest filing, up from $1.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $145.4 million in Q4 2015 and bottomed at $1.7 million in Q4 2017.
  • Average Non-cash Items over 5 years is $53.1 million, with a median of $53.3 million recorded in 2014.
  • Peak YoY movement for Non-cash Items: crashed 94.98% in 2016, then skyrocketed 3311.76% in 2018.
  • A 5-year view of Non-cash Items shows it stood at $53.3 million in 2014, then skyrocketed by 172.8% to $145.4 million in 2015, then crashed by 94.98% to $7.3 million in 2016, then crashed by 76.71% to $1.7 million in 2017, then surged by 3311.76% to $58.0 million in 2018.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $58.0 million in Q4 2018, $1.7 million in Q4 2017, and $7.3 million in Q4 2016.